2C-B-AN #
| Common Nomenclature | 2C-B-AN |
| Street & Reference Names | N/A |
| Reference Dosage | Light 30mg+; Common 45mg+; Strong 70mg+; Heavy 100mg+ [TripSit] |
| Anticipated: Onset / Duration | 1 Hour / 7 Hours |
| Maximum Dose Experienced | 55mg+10mg |
| Form | Powder |
| RoA | Oral |
| Source / Jurisdiction | Internet / UK |
| Personal Rating On Shulgin Scale | ++ |
SUBJECTIVE EXPERIENCE #
A small supply of this appeared on the market in 2016, shortly before the general UK ban came into effect. I was fortunate to obtain enough for a couple of low-dose trips.
These were pleasant enough: enhanced colouration with minor visuals, a sense of mood lift with mild euphoria, and a tingly body feel as experienced with other 2C-B variants.
The difference between many of these analogues is often subtle and difficult to distinguish, particularly with respect to headspace. It could well be that this one converts to 2C-B itself in vivo, as I have seen suggested.
Overall, this was a very nice foray, with the relatively short duration being a positive in my circumstances at the time. It was certainly trippy in nature, and I was almost back to baseline after about 6 hours.